Cyclopharm Ltd (CYC) – Strategy, SWOT and Corporate Finance Report
- Pages: 46
- Published: June 2023
- Report Code: MLPH82495FSA
Cyclopharm Ltd (CYC) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company
Key Highlights
Cyclopharm Ltd (Cyclopharm) is a radiopharmaceutical company that manufactures medical and healthcare equipment and components in nuclear medicine. The company’s products include Technegas, an ultra-fine dispersion of technetium-labelled carbon used for the detection of pulmonary embolism. The company is evaluating Technegas in new indications including chronic obstructive pulmonary disease (COPD), lung cancer, pulmonary hypertension, lung volume reduction and asthma. Cyclopharm operates a joint venture, Macquarie Medical Imaging, which provides diagnostic imaging services such as magnetic resonance imaging (MRI), computed tomography (CT), breast imaging, X-ray, ultrasound, dual-energy X-ray absorptiometry (DEXA) and positron emission tomography (PET) scanning. It harnesses its Ultralute technology, which extends the life of Molybdenum-99 generators. It operates in Asia Pacific, Canada, Latin America, Europe and Germany. Cyclopharm is headquartered in New South Wales, Australia.
Scope
• Detailed information on Cyclopharm Ltd required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Cyclopharm Ltd in the form of a SWOT analysis
• An in-depth view of the business model of Cyclopharm Ltd including a breakdown and examination of key business segments
• News about Cyclopharm Ltd, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of Cyclopharm Ltd and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Cyclopharm Ltd as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Cyclopharm Ltds business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Telix Pharmaceuticals Ltd
PETNET Solutions Cleveland LLC
Optiscan Imaging Ltd
Kent Hospital
China Wah Yan Healthcare Ltd
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.